Dr. Chevalier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 E 70th St
New York, NY 10021Phone+1 212-746-1578Fax+1 212-288-8370
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 2004 - 2006
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2000 - 2003
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
- NY State Medical License 2001 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 37 citationsBortezomib for Reduction of Proteinuria in IgA Nephropathy.Choli Hartono, Miriam Chung, Alan S Perlman, James M. Chevalier, David Serur
Kidney International Reports. 2018-03-11 - 71 citationsSerum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy.Alan S Perlman, James M. Chevalier, Patrick Wilkinson, Hao Liu, Thomas S. Parker
Annals of Clinical and Laboratory Science. 2015-05-01 - 36 citationsCollapsing glomerulopathy superimposed on diabetic nephropathy: insights into etiology of an under-recognized, severe pattern of glomerular injurySteven P. Salvatore, Alluru S. Reddi, Chandra B. Chandran, James M. Chevalier, Chike N. Okechukwu
Nephrology, Dialysis, Transplantation. 2014-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: